TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 29.1nMAssay Description:Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black small volume microtiter plates, as previously described using r...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 29.1nMAssay Description:Table 4: In Vitro Biochemical Analysis of PTP4A Inhibition. Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black sma...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 43.2nMAssay Description:Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black small volume microtiter plates, as previously described using r...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 43.2nMAssay Description:Table 4: In Vitro Biochemical Analysis of PTP4A Inhibition. Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black sma...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 49nMAssay Description:Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black small volume microtiter plates, as previously described using r...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 49nMAssay Description:Table 4: In Vitro Biochemical Analysis of PTP4A Inhibition. Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black sma...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 50nMAssay Description:Inhibition of PTP4A1 (unknown origin) expressed in Escherichia coli assessed as reduction in hydrolysis using DIFMUP as substrate incubated for 30 mi...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 130nMAssay Description:Inhibition of full-length human brain His6-tagged PRL-1 expressed in Escherichia coli using TAMRA-Thr-Ala-Asp-Ile-Tyr(PO3H2)-Glu-NH2 peptide as subst...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 133nMAssay Description:Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black small volume microtiter plates, as previously described using r...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 133nMAssay Description:Table 4: In Vitro Biochemical Analysis of PTP4A Inhibition. Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black sma...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 170nMAssay Description:Inhibition of recombinant human His-6-tagged PTP4A1 expressed in Escherichia coli assessed as increase in polarization using TAMRAThr-Ala-Asp-Ile-Tyr...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 173nMAssay Description:Inhibition of full length human fusion His6 tagged PRL1 expressed in Escherichia coli using TAMRA-Thr-Ala-Asp-Ile-Tyr(PO3H2)-Glu-NH2 substrate by imm...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 300nMAssay Description:Inhibition of PTP4A1 (unknown origin)More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 676nMAssay Description:Inhibition of human PTP4A1 by enzyme assayMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.00E+3nMAssay Description:Table 4: In Vitro Biochemical Analysis of PTP4A Inhibition. Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black sma...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.00E+3nMAssay Description:Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black small volume microtiter plates, as previously described using r...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of PRL1More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of PTP4A1 (unknown origin)More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 2.10E+4nMAssay Description:Inhibition of PRL1More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 3.13E+4nMAssay Description:Inhibition of PRL1 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 3.72E+4nMAssay Description:Inhibition of PRL1More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 3.98E+4nMAssay Description:Inhibition of PRL1More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human PRL1 expressed in Escherichia coli after 5 mins by microplate spectrophotometer analysisMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human PRL1 expressed in Escherichia coli after 5 mins by microplate spectrophotometer analysisMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human PRL1 expressed in Escherichia coli after 5 mins by microplate spectrophotometer analysisMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 5.67E+4nMAssay Description:Inhibition of PRL1 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 7.00E+4nMAssay Description:Inhibition of PRL1 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 7.01E+4nMAssay Description:Inhibition of PRL1 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 8.91E+4nMAssay Description:Inhibition of PRL1 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of PRL1More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of PRL1More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of PRL1More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.33E+5nMAssay Description:Inhibition of PRL1 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 2.09E+5nMAssay Description:Inhibition of PRL1 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 1(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 2.09E+5nMAssay Description:Inhibition of PRL1 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
